Anti-IL-18 antibody [EPR19954]
- RabMAb
- Recombinant
- KO Validated
- 20ul selling size
- What is this?
Be the first to review this product! Submit a review
|
(21 Publications)
Rabbit Recombinant Monoclonal IL-18 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 21 publications.
View Alternative Names
IGIF, IL1F4, IL18, Interleukin-18, IL-18, Iboctadekin, Interferon gamma-inducing factor, Interleukin-1 gamma, IFN-gamma-inducing factor, IL-1 gamma
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-IL-18 antibody [EPR19954] (AB207324)
Flow cytometry overlay histogram showing left PC3 positive cells and right negative Jurkat stained with ab207324 (red line). The cells were fixed with 4% formaldehyde (10 min) and then permeabilised with 0.1% PBS-Triton X-100 for 15 mins. The cells were then incubated in 1x PBS containing 10% normal goat serum to block non-specific protein-protein interaction followed by the antibody (ab207324) (1x 106 in 100μl at 1μg/ml (1/2,500 dilution)) for 30 mins at 22°C.
The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/2000 dilution for 30 mins at 22°C
Isotype control antibody (black line) was Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control used at the same concentration and conditions as the primary antibody. Unlabelled sample (blue line) was also used as a control.
Acquisition of >5000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-IL-18 antibody [EPR19954] (AB207324)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed PC-3 (Human prostate adenocarcinoma cell line) cells labeling IL-18with ab207324 at 1/60 dilution (red) compared with Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat Anti-Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-IL-18 antibody [EPR19954] (AB207324)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed HaCaT (Human keratinocyte cell line) cells labeling IL-18with ab207324 at 1/60 dilution (red) compared with Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730; black) and an unlabeled control (cells without incubation with primary antibody and secondary antibody; blue). Goat Anti-Rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-IL-18 antibody [EPR19954] (AB207324)
Intracellular flow cytometric analysis of 4% paraformaldehyde-fixed Jurkat (Human T cell leukemia cell line from peripheral blood) cells labeling IL-18with ab207324 at 1/60 dilution (red) compared with a rabbit monoclonal IgG isotype control (ab172730; black) and an unlabelled control (cells without incubation with primary antibody and secondary antibody; blue). Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody.
Negative control :
Jurkat cells serve as a negative cell line as described in PMID 15086390.
- WB
Supplier Data
Western blot - Anti-IL-18 antibody [EPR19954] (AB207324)
Blocking/Dilution buffer : 5% NFDM/TBST.
The WB profiles are consistent with the literature (PMID 12918059; PMID 11470273).
All lanes:
Western blot - Anti-IL-18 antibody [EPR19954] (ab207324) at 1/1000 dilution
Lane 1:
PC-3 (Human prostate adenocarcinoma cell line) whole cell lysate at 10 µg
Lane 2:
HaCaT (Human keratinocyte cell line) whole cell lysate at 10 µg
Lane 3:
HeLa (Human epithelial cell line from cervix adenocarcinoma) whole cell lysate at 10 µg
Lane 4:
Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/50000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 3min
- WB
Lab
Western blot - Anti-IL-18 antibody [EPR19954] (AB207324)
Lanes 1-4 : Merged signal (red and green). Green - ab207324 observed at 22 kDa. Red - loading control ab8245 observed at 37 kDa.
ab207324 Anti-IL-18 antibody [EPR19954] was shown to specifically react with IL-18 in wild-type HeLa cells. Loss of signal was observed when knockout cell line ab265274 (knockout cell lysate ab256952) was used. Wild-type and IL-18 knockout samples were subjected to SDS-PAGE. ab207324 and Anti-alpha Tubulin antibody [EP1332Y] - Microtubule Marker (ab52866) were incubated overnight at 4°C at 1 in 200 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-IL-18 antibody [EPR19954] (ab207324) at 1/200 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
IL18 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human IL18 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-il18-knockout-hela-cell-line-ab265274'>ab265274</a>)
Lane 3:
A431 cell lysate at 20 µg
Lane 4:
Jurkat cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/20000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
- WB
Lab
Western blot - Anti-IL-18 antibody [EPR19954] (AB207324)
Lanes 1 - 2 : Merged signal (red and green). Green - ab207324 observed at 22 kDa. Red - loading control, ab9484, observed at 37 kDa.
ab207324 was shown to recognize IL-18 in wild-type HEK293 cells as signal was lost at the expected MW in IL-18 knockout cells. Additional cross-reactive bands were observed in the wild-type and knockout cells. Wild-type and IL-18 knockout samples were subjected to SDS-PAGE. ab207324 and ab9484 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/200 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-IL-18 antibody [EPR19954] (ab207324) at 1/200 dilution
Lane 1:
Wild-type HEK-293 whole cell lysate at 20 µg
Lane 2:
IL-18 knockout HEK-293 whole cell lysate at 20 µg
Predicted band size: 22 kDa
false
- WB
Supplier Data
Western blot - Anti-IL-18 antibody [EPR19954] (AB207324)
Blocking/Dilution buffer : 5% NFDM/TBST.
Detection in skin and ovary required high concentration of antibody.
All lanes:
Western blot - Anti-IL-18 antibody [EPR19954] (ab207324) at 1/200 dilution
Lane 1:
Human skin lysate at 10 µg
Lane 2:
Human ovary cancer lysate at 10 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG Peroxidase Conjugate, specific to the non-reduced form of IgG at 1/5000 dilution
Predicted band size: 22 kDa
Observed band size: 22 kDa
false
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-IL-18 antibody [EPR19954] (AB207324)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-IL-18 antibody [EPR19954] (ab207324) at 1/1000 dilution
All lanes:
Human IL-18 active protein at 0.02 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 22 kDa
Observed band size: 17 kDa
false
Exposure time: 3min
Related conjugates and formulations (1)
-
Anti-IL-18 antibody [EPR19954] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (21)
Recent publications for all applications. Explore the full list and refine your search
Inflammation : PubMed40372612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:647 PubMed39434141
2024
Applications
Unspecified application
Species
Unspecified reactive species
Open medicine (Warsaw, Poland) 19:20240973 PubMed38919547
2024
Applications
Unspecified application
Species
Unspecified reactive species
Naunyn-Schmiedeberg's archives of pharmacology 397:7951-7962 PubMed38758227
2024
Applications
Unspecified application
Species
Unspecified reactive species
World journal of gastroenterology 30:252-267 PubMed38314135
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 21:419 PubMed37957714
2023
Applications
Unspecified application
Species
Unspecified reactive species
Annals of translational medicine 10:1058 PubMed36330410
2022
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 57:1496-1511.e6 PubMed35675813
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 9:828240 PubMed35733856
2022
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 9:874916 PubMed35692535
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com